(Reuters) -AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal ...
A weight loss supplement has been given the FDA's highest recall classification after being pulled from shelves in December.
The snacks are now part of a Class I recall, which is for products with the potential of "serious adverse health consequences ...
Last year, California-based grocery producer Braga Fresh voluntarily issued a precautionary recall of 12-ounce washed and ...
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...
The Trump administration’s overarching message to the legions of people powering the federal government is simple: Leave.
On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...
The FDA has approved the intravenous antibiotic Emblaveo for adults with complicated intra-abdominal infections who have limited treatment options.
The U.S. Food and Drug Administration (FDA) has given its second most serious risk level, Class II, to a product from D. Coluccio & Sons. The recalled product is a 300 gram pack of chocolate chip ...
It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.
Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...
A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results